Tag: Alembic
Browse our exclusive articles!
Alembic Pharma gets USFDA nod for thyroid disorder and cancer treatment drug
Alembic Pharmaceuticals Ltd. on Friday, May 22, said it has received the final approval from the US Food and Drug Administration (USFDA) for its...
Alembic Pharma shares rise on USFDA nod for prostate cancer drug with $3 billion estimated market size
Shares of Alembic Pharmaceuticals Ltd. gained nearly 3% on Thursday, May 14, after the company received a tentative approval from the US Food and...
Alembic Pharma shares gain after drugmaker gets USFDA approval for cancer treatment drug
Alembic Pharmaceuticals Ltd. on Thursday, April 16, said it has received final approval from the US Food and Drug Administration (USFDA) for its generic...
Alembic Pharma gains 4% on USFDA nod for key diabetes drug
Shares of Alembic Pharmaceuticals Ltd. rose over 4% on Tuesday, April 7, after the company received final approval from the US Food and Drug...
Alembic Pharma gets USFDA nod for anti-seizure drug but stock sees volatile moves
Alembic Pharmaceuticals Ltd. on Thursday, February 26, announced that it has received final approval from the US health regulator, the US Food and Drug...
